Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2017-02-16
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Coded data are used.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patterns and Outcome of Autoimmune Related Liver Disease
NCT03898414
Autoimmune Hepatitis Study
NCT00286663
Autoimmune Hepatitis Cohort in China
NCT05785793
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
NCT06356506
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
NCT06078098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Measurements and procedures: Enrolment visit and one follow-up visit at least once a year are planned. An additional follow-up visit at 6 months postdiagnosis is planned for newly diagnosed patients.
Whole blood is collected for biobanking once a year Optionally, if available and collected during normal clinical procedures, liver fragments are obtained.
Number of subjects projected for the entire study (all sites combined): 500 (corresponding to 1/3 of the estimated global AIH population residing in Switzerland, assuming a disease prevalence of 20:100,000)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Only patients living in Switzerland
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Epatocentro Ticino
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Epatocentro Ticino
Lugano, Canton Ticino, Switzerland
Gastroenterologie und Hepatologie Clarunis - Universitäres Bauchzentrum, Universitätsspital Basel
Basel, , Switzerland
Universitäts-Kinderspital beider Basel UKBB, Gastroenterologie&Ernährung
Basel, , Switzerland
Inselspital
Bern, , Switzerland
Kinderklinik, INSELSpital, Universität Bern, Pädiatrische Gastroenterologie, Hepatologie und Ernährung
Bern, , Switzerland
Kantonsspital Graubünden
Chur, , Switzerland
Hôpitaux Universitaires de Genève, Centre Suisse des Maladies du foie de l'Enfant- Département de l'Enfant et de l'Adolescent
Geneva, , Switzerland
Hôpitaux Universitaires de Genève, Service de Gastroentérologie & Hépatologie, Département des Spécialités
Geneva, , Switzerland
CHUV: Centre hospitalier universitaire vaudois
Lausanne, , Switzerland
CHUV Département femme-mère-enfant
Lausanne, , Switzerland
Kantonsspital Baselland
Liestal, , Switzerland
Kinderspital Luzern LUKS, Pädiatrische Gastroenterologie
Lucerne, , Switzerland
Luzerner Kantonsspital
Lucerne, , Switzerland
EOC Ospedale Regionale di Lugano - Italiano
Lugano, , Switzerland
Ostschweizer Kinderspital
Sankt Gallen, , Switzerland
Kantonsspital St.Gallen
Sankt Gallen, , Switzerland
Kantonsspital Winterthur
Winterthur, , Switzerland
Kinderspital Winterthur, Klinik für Gastroenterologie & Hepatologie
Winterthur, , Switzerland
Universitäts-Kinderspital Zürich - Eleonorenstiftung
Zurich, , Switzerland
Universitätsspital Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SASL38 - Swiss AIH Cohort
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.